Day
| 11 | 48 | 55 | 118 | 150 | 158 | 165 | 180 | 230 | 237 |
Therapy
| CTX, ST | – | – | ST | ST | ST, AC | ST, AC, CY | ST, AC, CY | AC | AC, ST, CY |
Cerebrospinal fluid findings
| | | | | | | | | | |
Red blood cells (per ml) | 7 | 2 | 2 | – | 17 | | | | | 1 |
White blood cells (per ml) | 400 | 92 | 118 | 22 | 4 | | | | | 16 |
Polymorphonuclear cells (%) | 74 | 12 | 16 | 1 | – | | | | | 0 |
Lymphocytes (%) | 19 | 73 | 70 | 96 | – | | | | | 94 |
Monocytes (%) | 7 | 15 | 14 | 3 | 100 | | | | | 6 |
Protein (mg/dl) | 224 | 96 | 100 | 84 | 27 | | | | | 43 |
Glucose (mg/dl) | 56 | 45 | 40 | 56 | 67 | | | | | 72 |
Anti-phospholipid antibodies
| | | | | | | | | | |
Anti-β2-glycoprotein 1 (IgG; SGU) reference range: 0–9 | | | | 29 | 56 | | | 24 | 52 | |
TCD mean flow velocities (cm/sec)
| | | | | | | | | | |
Right MCA, reference velocity: 58 | | | | 164 | 312 | 157 | 287 | 195 | | 350 |
Left MCA, reference velocity: 58 | | | | 309 | 337 | 334 | 344 | 328 | | NI |
Right VA, reference velocity: 45 | | | | 193 | 245 | 105 | 107 | 91 | | 64 |
Left VA, reference velocity: 45 | | | | 231 | 121 | 140 | 108 | 176 | | 169 |
Basilar artery, reference velocity: 38 | | | | NI | 162 | 119 | 193 | 114 | | 136 |